MSD's Keytruda is poised to end a 20-year drought in new advances in NHS treatment for early-stage head and neck cancer, ...

Gilead Sciences has built up its position in the hot area of T-cell engagers (TCEs) for autoimmune diseases with an agreement ...

At BIO-Europe Spring 2026 in Lisbon, Portugal web editor Nicole Raleigh sat down with Robert Jacks, CEO of Sparrow ...

As health systems seek to balance innovation with the need to address sustainability, increasing attention is being paid to ...

California biotech Kali Therapeutics has snagged its first major pharma partner, Sanofi, which is committing $180 million in ...

Valneva and Pfizer's three-dose shot targets the outer surface protein A (OspA) of the Borrelia burgdorfii bacteria that ...

Dizal Pharmaceutical's Zegfrovy has taken the EGFR inhibitor class into new territory after hitting the mark in a phase 3 ...

The FDA has scheduled a public meeting to discuss its Commissioner's National Priority Voucher (CNPV) programme, amid ...

Novo Nordisk is facing generics of its GLP-1 drug in India, Atrogi is testing a new weight loss approach, and there's new ...

Earendil Labs has raised an impressive $787 million in financing for its AI-powered drug discovery and development platform, ...

A phase 2 trial has shown promising protective efficacy for what could become the first vaccine against hookworm, a parasitic ...

After a strong start to the year, the value of biotech financings has tailed off a little, but March has seen a clutch of $50 ...